Rights and permissions
About this article
Cite this article
US physicians eagerly await approval of new HCV drugs. Pharmacoecon. Outcomes News 616, 11 (2010). https://doi.org/10.2165/00151234-201006160-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006160-00038